ESMO 2021 | ESMO 2021 highlights in colorectal cancer

Claudia Cardone, MD, Istituto Nazionale Tumori-IRCCS Fondazione “G. Pascale”, Naples, Italy, discusses her highlights from the European Society for Medical Oncology (ESMO) 2021 Congress, including the AtezoTRIBE trial (NCT03721653), the MAYA trial (NCT03832621), and the KRYSTAL-1 trial (NCT03785249). This interview took place at the ESMO 2021 Congress.